| Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED) (NCT00060632) | Merck Sharp & Dohme LLC | 2003-04-01 |
| Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma (NCT00071955) | Genitope Corporation | 2003-03-01 |
| Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00062296) | Fox Chase Cancer Center | 2003-03-01 |
| A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies (NCT00621244) | Novartis Pharmaceuticals | 2003-03-01 |
| Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma (NCT00505921) | M.D. Anderson Cancer Center | 2003-03-01 |
| Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma (NCT00052923) | Eastern Cooperative Oncology Group | 2003-03-01 |
| Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma (NCT00060385) | European Organisation for Research and Treatment of Cancer - EORTC | 2003-03-01 |
| Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma (NCT00058422) | Memorial Sloan Kettering Cancer Center | 2003-02-10 |
| Exercise Program for Adolescents and Young Adults With Cancer (NCT00502749) | M.D. Anderson Cancer Center | 2003-02-01 |
| Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET (NCT00583323) | Mayo Clinic | 2003-02-01 |
| Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma (NCT00053027) | Alliance for Clinical Trials in Oncology | 2003-02-01 |
| Fludara (Oral) Phase II Study for Indolent Lymphoma (NCT00688883) | Genzyme, a Sanofi Company | 2003-02-01 |
| BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma (NCT00061880) | BioCryst Pharmaceuticals | 2003-02-01 |
| Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders (NCT00055653) | Roswell Park Cancer Institute | 2003-01-01 |
| Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen (NCT00074165) | OHSU Knight Cancer Institute | 2003-01-01 |
| Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma (NCT00068302) | Children's Hospital of Philadelphia | 2003-01-01 |
| Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NCT00059904) | Memorial Sloan Kettering Cancer Center | 2003-01-01 |
| MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma (NCT00059995) | Memorial Sloan Kettering Cancer Center | 2003-01-01 |
| Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer (NCT00301860) | University of California, San Francisco | 2003-01-01 |
| Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides (NCT00056056) | European Organisation for Research and Treatment of Cancer - EORTC | 2003-01-01 |
| Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer (NCT00053053) | Radiation Therapy Oncology Group | 2002-12-01 |
| Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer (NCT00265837) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-12-01 |
| Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00098566) | Fred Hutchinson Cancer Center | 2002-12-01 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer (NCT00053196) | Alliance for Clinical Trials in Oncology | 2002-12-01 |
| Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma (NCT00028691) | Commissie Voor Klinisch Toegepast Onderzoek | 2002-12-01 |
| Bortezomib in Treating Patients With Mantle Cell Lymphoma (NCT00030875) | NCIC Clinical Trials Group | 2002-11-19 |
| Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies (NCT00113646) | Massachusetts General Hospital | 2002-11-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma (NCT00416832) | Christine Mauz-Körholz | 2002-11-01 |
| Unrelated Donor Transplant for Malignant and Non-Malignant Disorders (NCT01050439) | Columbia University | 2002-11-01 |
| Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma (NCT00041327) | AIDS Malignancy Consortium | 2002-10-01 |
| Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma (NCT00053092) | Institute of Cancer Research, United Kingdom | 2002-10-01 |
| Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00058396) | Memorial Sloan Kettering Cancer Center | 2002-10-01 |
| Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies (NCT00048737) | M.D. Anderson Cancer Center | 2002-10-01 |
| Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00052416) | Beth Israel Deaconess Medical Center | 2002-10-01 |
| A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma (NCT01609010) | Hoffmann-La Roche | 2002-10-01 |
| Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders (NCT00052572) | Memorial Sloan Kettering Cancer Center | 2002-10-01 |
| Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma (NCT00049712) | University of Wisconsin, Madison | 2002-10-01 |
| VNP40101M in Treating Patients With Advanced or Metastatic Cancer (NCT00049699) | Vion Pharmaceuticals | 2002-10-01 |
| Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma (NCT00045539) | New Approaches to Brain Tumor Therapy Consortium | 2002-10-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer (NCT00304018) | University of California, San Francisco | 2002-10-01 |
| Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma (NCT00055640) | Case Comprehensive Cancer Center | 2002-10-01 |
| Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma (NCT00068146) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-09-19 |
| S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma (NCT00041132) | SWOG Cancer Research Network | 2002-09-01 |
| Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment (NCT00210249) | Institut Bergonié | 2002-09-01 |
| Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma (NCT00594815) | Memorial Sloan Kettering Cancer Center | 2002-08-28 |
| Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma (NCT00416923) | University of California, San Francisco | 2002-08-01 |
| Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma (NCT00049595) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-08-01 |
| Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer (NCT00058045) | Roswell Park Cancer Institute | 2002-08-01 |
| Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia (NCT00045695) | NCIC Clinical Trials Group | 2002-08-01 |
| 10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma (NCT00052442) | Spectrum Pharmaceuticals, Inc | 2002-08-01 |
| Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure (NCT01160315) | Erasme University Hospital | 2002-07-01 |
| Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab (NCT00208975) | Emory University | 2002-07-01 |
| Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma (NCT00055783) | Stanford University | 2002-07-01 |
| Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer (NCT00255710) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-07-01 |
| Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma (NCT00045513) | University Health Network, Toronto | 2002-06-01 |
| Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia (NCT00053157) | Roswell Park Cancer Institute | 2002-06-01 |
| Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma (NCT00049413) | Hoag Memorial Hospital Presbyterian | 2002-06-01 |
| UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma (NCT00045500) | National Cancer Institute (NCI) | 2002-06-01 |
| Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma (NCT00080886) | University of Nebraska | 2002-05-08 |
| FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma (NCT00042822) | Memorial Sloan Kettering Cancer Center | 2002-05-01 |
| Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma (NCT00042913) | Jonsson Comprehensive Cancer Center | 2002-05-01 |
| Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia (NCT00039130) | Alliance for Clinical Trials in Oncology | 2002-05-01 |
| Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia (NCT00054236) | Case Comprehensive Cancer Center | 2002-05-01 |
| Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer (NCT00062231) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-04-01 |
| Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma (NCT00053768) | German High-Grade Non-Hodgkin's Lymphoma Study Group | 2002-04-01 |
| CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy (NCT00031941) | National Institutes of Health Clinical Center (CC) | 2002-04-01 |
| Pyroxamide in Treating Patients With Advanced Cancer (NCT00042900) | Memorial Sloan Kettering Cancer Center | 2002-04-01 |
| Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy (NCT00303719) | Masonic Cancer Center, University of Minnesota | 2002-03-26 |
| Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma (NCT00039351) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-03-01 |
| Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia (NCT00041379) | LifeTime Pharmaceuticals | 2002-03-01 |
| Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer (NCT00053118) | Roswell Park Cancer Institute | 2002-03-01 |
| Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00040950) | Jonsson Comprehensive Cancer Center | 2002-03-01 |
| Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma (NCT00265889) | Case Comprehensive Cancer Center | 2002-02-01 |
| Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study (NCT00169598) | Hospices Civils de Lyon | 2002-02-01 |
| Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer (NCT00036790) | University of Wisconsin, Madison | 2002-02-01 |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (NCT00053105) | Theradex | 2002-02-01 |
| Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma (NCT00032019) | Alliance for Clinical Trials in Oncology | 2002-02-01 |
| Simultaneous Care: Linking Palliation to Clinical Trials (NCT00283257) | University of California, Davis | 2002-02-01 |
| NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders (NCT00053989) | Roswell Park Cancer Institute | 2002-01-29 |
| Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy (NCT01521611) | University Hospital Southampton NHS Foundation Trust | 2002-01-01 |
| BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma (NCT00039156) | Theradex | 2002-01-01 |
| Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00301912) | University of California, San Francisco | 2002-01-01 |
| Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation (NCT00036712) | Medical College of Wisconsin | 2002-01-01 |
| Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation (NCT00031642) | University of Nebraska | 2002-01-01 |
| Subcutaneous Amifostine Safety Study (NCT00158041) | Mt. Sinai Medical Center, Miami | 2002-01-01 |
| FR901228 in Treating Patients With Hematologic Cancer (NCT00024180) | Ohio State University Comprehensive Cancer Center | 2002-01-01 |
| Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support (NCT00070616) | Swedish Orphan Biovitrum | 2001-12-01 |
| Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma (NCT00047021) | Case Comprehensive Cancer Center | 2001-11-01 |
| Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation (NCT00154440) | Technische Universität Dresden | 2001-11-01 |
| VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma (NCT00036946) | Regeneron Pharmaceuticals | 2001-11-01 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders (NCT00544115) | City of Hope Medical Center | 2001-10-16 |
| Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma (NCT00030849) | Memorial Sloan Kettering Cancer Center | 2001-10-01 |
| Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma (NCT00031902) | Lymphoma Trials Office | 2001-10-01 |
| Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL (NCT00041288) | University of Texas Southwestern Medical Center | 2001-10-01 |
| Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma (NCT00041210) | Mount Vernon Cancer Centre at Mount Vernon Hospital | 2001-10-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma (NCT00032149) | Lymphoma Trials Office | 2001-10-01 |
| Mediastinal Recurrence of Lympho-proliferative Disorders: a Biopsy is Needed (NCT06714045) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2001-09-12 |
| Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia (NCT00020865) | Jonsson Comprehensive Cancer Center | 2001-09-01 |
| Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease (NCT00388349) | Stanford University | 2001-09-01 |
| Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases (NCT00038857) | M.D. Anderson Cancer Center | 2001-09-01 |